Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MWN117 in Healthy and Obese Participants
NCT07824804Phase 1Not yet recruiting
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd.
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of MWN117 in obesity (2 arms), sponsored by Shanghai Minwei Biotechnology Co., Ltd. Primary endpoint: Incidence of Adverse Events. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
MWN117
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07824804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07824804.